associated laboratories limited Company Information
Company Number
05272224
Next Accounts
Dec 2025
Shareholders
brian patrick flood
peter gordon wagon
Group Structure
View All
Industry
Manufacture of medical and dental instruments and supplies
Registered Address
5/6 chalice close chalice close, wallington, SM6 9RU
associated laboratories limited Estimated Valuation
Pomanda estimates the enterprise value of ASSOCIATED LABORATORIES LIMITED at £602.3k based on a Turnover of £652.1k and 0.92x industry multiple (adjusted for size and gross margin).
associated laboratories limited Estimated Valuation
Pomanda estimates the enterprise value of ASSOCIATED LABORATORIES LIMITED at £369.2k based on an EBITDA of £69.9k and a 5.28x industry multiple (adjusted for size and gross margin).
associated laboratories limited Estimated Valuation
Pomanda estimates the enterprise value of ASSOCIATED LABORATORIES LIMITED at £922.7k based on Net Assets of £413.4k and 2.23x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Associated Laboratories Limited Overview
Associated Laboratories Limited is a live company located in wallington, SM6 9RU with a Companies House number of 05272224. It operates in the manufacture of medical and dental instruments and supplies sector, SIC Code 32500. Founded in October 2004, it's largest shareholder is brian patrick flood with a 50% stake. Associated Laboratories Limited is a mature, small sized company, Pomanda has estimated its turnover at £652.1k with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Associated Laboratories Limited Health Check
Pomanda's financial health check has awarded Associated Laboratories Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 6 measures and has 3 areas for improvement. Company Health Check FAQs


6 Strong

2 Regular

3 Weak

Size
annual sales of £652.1k, make it smaller than the average company (£16.5m)
- Associated Laboratories Limited
£16.5m - Industry AVG

Growth
3 year (CAGR) sales growth of 14%, show it is growing at a faster rate (6.2%)
- Associated Laboratories Limited
6.2% - Industry AVG

Production
with a gross margin of 37.4%, this company has a comparable cost of product (37.4%)
- Associated Laboratories Limited
37.4% - Industry AVG

Profitability
an operating margin of 8.5% make it more profitable than the average company (6%)
- Associated Laboratories Limited
6% - Industry AVG

Employees
with 7 employees, this is below the industry average (93)
7 - Associated Laboratories Limited
93 - Industry AVG

Pay Structure
on an average salary of £49k, the company has an equivalent pay structure (£49k)
- Associated Laboratories Limited
£49k - Industry AVG

Efficiency
resulting in sales per employee of £93.2k, this is less efficient (£168.5k)
- Associated Laboratories Limited
£168.5k - Industry AVG

Debtor Days
it gets paid by customers after 33 days, this is earlier than average (50 days)
- Associated Laboratories Limited
50 days - Industry AVG

Creditor Days
its suppliers are paid after 42 days, this is slower than average (36 days)
- Associated Laboratories Limited
36 days - Industry AVG

Stock Days
There is insufficient data available for this Key Performance Indicator!
- Associated Laboratories Limited
- - Industry AVG

Cash Balance
has cash to cover current liabilities for 156 weeks, this is more cash available to meet short term requirements (14 weeks)
156 weeks - Associated Laboratories Limited
14 weeks - Industry AVG

Debt Level
it has a ratio of liabilities to total assets of 22.4%, this is a lower level of debt than the average (42%)
22.4% - Associated Laboratories Limited
42% - Industry AVG
ASSOCIATED LABORATORIES LIMITED financials

Associated Laboratories Limited's latest turnover from March 2024 is estimated at £652.1 thousand and the company has net assets of £413.4 thousand. According to their latest financial statements, Associated Laboratories Limited has 7 employees and maintains cash reserves of £360 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | 842,084 | 795,113 | |||||||||||||
Other Income Or Grants | |||||||||||||||
Cost Of Sales | 432,157 | 405,119 | |||||||||||||
Gross Profit | 409,927 | 389,994 | |||||||||||||
Admin Expenses | 241,097 | 229,939 | |||||||||||||
Operating Profit | 168,830 | 160,055 | |||||||||||||
Interest Payable | 65 | 247 | |||||||||||||
Interest Receivable | |||||||||||||||
Pre-Tax Profit | 168,765 | 159,808 | |||||||||||||
Tax | -34,558 | -32,026 | |||||||||||||
Profit After Tax | 134,207 | 127,782 | |||||||||||||
Dividends Paid | 102,600 | ||||||||||||||
Retained Profit | 31,607 | 127,782 | |||||||||||||
Employee Costs | |||||||||||||||
Number Of Employees | 7 | 7 | 7 | 7 | 3 | 3 | 11 | 11 | |||||||
EBITDA* | 189,267 | 186,306 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 108,182 | 95,461 | 110,177 | 103,062 | 115,186 | 127,576 | 30,951 | 69,939 | 32,783 | 58,531 | 63,018 | 67,845 | 62,382 | 26,232 | 26,023 |
Intangible Assets | 5,482 | 14,882 | 24,282 | 33,682 | 43,082 | ||||||||||
Investments & Other | |||||||||||||||
Debtors (Due After 1 year) | |||||||||||||||
Total Fixed Assets | 108,182 | 95,461 | 110,177 | 103,062 | 115,186 | 127,576 | 30,951 | 69,939 | 32,783 | 58,531 | 68,500 | 82,727 | 86,664 | 59,914 | 69,105 |
Stock & work in progress | |||||||||||||||
Trade Debtors | 59,300 | 20,187 | 34,875 | 12,994 | 65,834 | 73,231 | 100,375 | 109,029 | 128,258 | 144,170 | 136,177 | 186,536 | 146,351 | 165,963 | 145,440 |
Group Debtors | |||||||||||||||
Misc Debtors | 5,303 | 5,303 | 15,606 | 15,719 | 15,026 | 627 | 1,986 | 1,750 | 3,409 | 16,678 | 16,727 | ||||
Cash | 359,984 | 320,578 | 232,272 | 339,395 | 223,430 | 303,498 | 324,246 | 272,812 | 329,434 | 263,487 | 238,070 | 127,715 | 125,528 | 66,166 | 48,449 |
misc current assets | 296 | ||||||||||||||
total current assets | 424,587 | 346,068 | 282,753 | 368,108 | 304,290 | 377,652 | 426,607 | 383,591 | 461,101 | 407,657 | 374,247 | 314,251 | 271,879 | 248,807 | 210,616 |
total assets | 532,769 | 441,529 | 392,930 | 471,170 | 419,476 | 505,228 | 457,558 | 453,530 | 493,884 | 466,188 | 442,747 | 396,978 | 358,543 | 308,721 | 279,721 |
Bank overdraft | |||||||||||||||
Bank loan | |||||||||||||||
Trade Creditors | 47,747 | 39,309 | 26,006 | 14,307 | 35,686 | 15,903 | 31,247 | 25,149 | 21,644 | 63,349 | 77,762 | 78,987 | 70,808 | 39,785 | 37,799 |
Group/Directors Accounts | 15,612 | 15,612 | 15,612 | 15,177 | 23,101 | ||||||||||
other short term finances | |||||||||||||||
hp & lease commitments | |||||||||||||||
other current liabilities | 56,021 | 27,995 | 23,695 | 26,383 | 25,724 | 39,443 | 29,753 | 23,183 | 39,398 | 45,449 | 50,042 | ||||
total current liabilities | 119,380 | 82,916 | 65,313 | 55,867 | 61,410 | 78,447 | 61,000 | 48,332 | 61,042 | 63,349 | 77,762 | 78,987 | 70,808 | 85,234 | 87,841 |
loans | 50,000 | ||||||||||||||
hp & lease commitments | |||||||||||||||
Accruals and Deferred Income | |||||||||||||||
other liabilities | |||||||||||||||
provisions | |||||||||||||||
total long term liabilities | 50,000 | ||||||||||||||
total liabilities | 119,380 | 82,916 | 65,313 | 105,867 | 61,410 | 78,447 | 61,000 | 48,332 | 61,042 | 63,349 | 77,762 | 78,987 | 70,808 | 85,234 | 87,841 |
net assets | 413,389 | 358,613 | 327,617 | 365,303 | 358,066 | 426,781 | 396,558 | 405,198 | 432,842 | 402,839 | 364,985 | 317,991 | 287,735 | 223,487 | 191,880 |
total shareholders funds | 413,389 | 358,613 | 327,617 | 365,303 | 358,066 | 426,781 | 396,558 | 405,198 | 432,842 | 402,839 | 364,985 | 317,991 | 287,735 | 223,487 | 191,880 |
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||||||
Operating Profit | 168,830 | 160,055 | |||||||||||||
Depreciation | 14,700 | 16,159 | 20,304 | 13,773 | 15,340 | 49,139 | 19,294 | 26,346 | 24,825 | 20,478 | 19,250 | 14,706 | 11,037 | 16,851 | |
Amortisation | 5,482 | 9,400 | 9,400 | 9,400 | 9,400 | 9,400 | |||||||||
Tax | -34,558 | -32,026 | |||||||||||||
Stock | |||||||||||||||
Debtors | 39,113 | -24,991 | 21,768 | -52,147 | 7,002 | -28,503 | -8,418 | -20,888 | -12,503 | 7,993 | -50,359 | 40,185 | -36,290 | 20,474 | 162,167 |
Creditors | 8,438 | 13,303 | 11,699 | -21,379 | 19,783 | -15,344 | 6,098 | 3,505 | -41,705 | -14,413 | -1,225 | 8,179 | 31,023 | 1,986 | 37,799 |
Accruals and Deferred Income | 28,026 | 4,300 | -2,688 | 659 | -13,719 | 9,690 | 6,570 | -16,215 | 39,398 | -45,449 | -4,593 | 50,042 | |||
Deferred Taxes & Provisions | |||||||||||||||
Cash flow from operations | 131,628 | 79,954 | |||||||||||||
Investing Activities | |||||||||||||||
capital expenditure | |||||||||||||||
Change in Investments | |||||||||||||||
cash flow from investments | |||||||||||||||
Financing Activities | |||||||||||||||
Bank loans | |||||||||||||||
Group/Directors Accounts | 435 | 15,177 | -23,101 | 23,101 | |||||||||||
Other Short Term Loans | |||||||||||||||
Long term loans | -50,000 | 50,000 | |||||||||||||
Hire Purchase and Lease Commitments | |||||||||||||||
other long term liabilities | |||||||||||||||
share issue | |||||||||||||||
interest | -65 | -247 | |||||||||||||
cash flow from financing | -65 | 63,851 | |||||||||||||
cash and cash equivalents | |||||||||||||||
cash | 39,406 | 88,306 | -107,123 | 115,965 | -80,068 | -20,748 | 51,434 | -56,622 | 65,947 | 25,417 | 110,355 | 2,187 | 59,362 | 17,717 | 48,449 |
overdraft | |||||||||||||||
change in cash | 39,406 | 88,306 | -107,123 | 115,965 | -80,068 | -20,748 | 51,434 | -56,622 | 65,947 | 25,417 | 110,355 | 2,187 | 59,362 | 17,717 | 48,449 |
associated laboratories limited Credit Report and Business Information
Associated Laboratories Limited Competitor Analysis

Perform a competitor analysis for associated laboratories limited by selecting its closest rivals, whether from the MANUFACTURING sector, other small companies, companies in SM6 area or any other competitors across 12 key performance metrics.
associated laboratories limited Ownership
ASSOCIATED LABORATORIES LIMITED group structure
Associated Laboratories Limited has no subsidiary companies.
Ultimate parent company
ASSOCIATED LABORATORIES LIMITED
05272224
associated laboratories limited directors
Associated Laboratories Limited currently has 2 directors. The longest serving directors include Mr Brian Flood (Oct 2004) and Lee McManus (Nov 2005).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Brian Flood | United Kingdom | 59 years | Oct 2004 | - | Director |
Lee McManus | 49 years | Nov 2005 | - | Director |
P&L
March 2024turnover
652.1k
+24%
operating profit
55.2k
0%
gross margin
37.4%
-4.14%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
413.4k
+0.15%
total assets
532.8k
+0.21%
cash
360k
+0.12%
net assets
Total assets minus all liabilities
associated laboratories limited company details
company number
05272224
Type
Private limited with Share Capital
industry
32500 - Manufacture of medical and dental instruments and supplies
incorporation date
October 2004
age
21
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
March 2024
previous names
N/A
accountant
JPR ACCOUNTANCY SOLUTIONS LTD
auditor
-
address
5/6 chalice close chalice close, wallington, SM6 9RU
Bank
-
Legal Advisor
-
associated laboratories limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 1 charges/mortgages relating to associated laboratories limited. Currently there are 1 open charges and 0 have been satisfied in the past.
associated laboratories limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for ASSOCIATED LABORATORIES LIMITED. This can take several minutes, an email will notify you when this has completed.
associated laboratories limited Companies House Filings - See Documents
date | description | view/download |
---|